REFERENCES
- Ahlstrand C, Carlsson P. Jönsson B. An estimate of the life-time cost of surgical treatment of patients with benign prostatic hyperplasia in Sweden. Scand J Urol Nephrol 1996; 30: 37–43.
- Carlsson P Spridning och ekonomiska effekter av medicinsk teknologi vid behandling av magsir, prosta-taförstoring och gallsten. Linkoping University, 1987 (Thesis).
- Chirikos TN, Sanford E. Cost consequences of surveil-lance, medical management or surgery for benign prostatic hyperplasia. J Urol 1996; 155: 1311–1316.
- Colton T Statistics in medicine. Boston: Little, Brown, 1974: 219–223.
- Dahlstrand C, Walden M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transur-ethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995; 76(5): 614–618.
- De Wildt MJAM, de-la-Rosette BMCH. Transurethral microwave thermotherapy: an evolving technology in the treatment of benign prostatic enlargement. Br J Urol 1995; 76: 531–538.
- de-la-Rosette BMCH, D'Ancona FCH, Debruyne FM. Current status of thermotherapy of the prostate. J Urol 1997; 157: 430–438.
- Dixon C. Lasers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 413–422.
- Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 1993; 71: 290–296.
- Hugosson J, Bergdahl S, Norlen L, Ortengren T. Outpatient transurethral incision of the prostate under local anesthesia: operative results, patient security and cost-effectiveness. Scand J Urol Nephrol 1993; 27(3): 381–385.
- Kabalin JN, Butler ED. Costs of minimally invasive laser surgery compared with transurethral electrocautery resection of the prostate. West J Med 1995; 162(5): 426–429.
- Keoghane SR, Lawrence KC, Gray AM, Chappel DB, Hancock AM, Cranston DW. The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy. Br J Urol 1996; 77: 386–390.
- Lepor H. Medical treatment for benign prostatic hyperplasia. Urology 1993; 42: 483–501.
- Lowe FC, McDaniel RL, Chmiel JJ, Hillman AL. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. Urology 1995; 46(4): 477–483.
- Walden M, Dahlstrand C, Schafer W, Pettersson S How to select patients suitable for transurethral microwave thermotherapy—a systematic evaluation of possibly predictive variables (Br J Urol in press).
- Walden M, Kihl B. Complications following transure-thral resection of the prostate. In: Bo B, ed. Swedish Association of Urology, Proceedings of the Annual Meeting. Stockholm: Scand J Urol Nephrol 1989: 30.
- Weibull H. Vad kostar virden? Patientrelaterad kost-nadsredovisning i KPP-projektet. Stockholm: SPRI, 1996: 132.
- Weis KA, Epstein RS, Huse DM, Deverka PA, Oster G. The costs of prostatectomy for benign prostatic hyperplasia. Prostate 1993; 22(4): 325–334.